At a moment when surgical robotics is crowded with capital intensity and competing promises, Anne Osdoit has chosen a different path. As CEO of Moon Surgical, Partner at Sofinnova Partners, and leading the VC firm’s medtech accelerator, MD Start, as an investor and a seasoned company builder, Osdoit is redefining innovation by starting not with replacement, but with collaboration. Here, she reflects on her journey from biomedical engineer to repeat medtech CEO, the conviction behind Moon Surgical’s human-centered, AI-powered surgical robotics platform, and the leadership mindset required to build the future of robotics by keeping surgeons, patients, and reality firmly at the center.
“There are 150 companies building surgical robots,” Anne Osdoit told the LSI Europe audience recently, while on stage giving a Moon Surgical presentation. “So why bother with another one?”
It was a question she had been asking herself for years.
Osdoit spent more than a decade evaluating surgical robotics opportunities across Europe and the U.S., first as an operator and later as an investor and company builder. She had seen the field fracture into two categories. Large, capital-intensive platforms designed to emulate Intuitive Surgical’s market-leading da Vinci model, and smaller but highly specialized robots built for single indications. Technically impressive systems that struggled to justify their cost or complexity once they met real clinical environments.
“We had looked at almost every robotic opportunity out there,” she told The Lens during a recent conversation. “And nothing felt quite right. Either it wasn’t differentiated enough, or it wasn’t large enough to matter.”
She pauses, then adds, “We were interested in robotics, but we were not interested in building something just because the category was hot.”
Moon Surgical would emerge not as a reaction to the industry’s dominant players, but as a response to what they had left behind.
The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry. The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry.
The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry. The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry.
The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry. The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry.
The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry.
The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry.
The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry.
The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry. The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry. The Lens is what the sharpest minds in medtech are reading to stay ahead. Packed with expert perspectives, market analysis, and high-impact insight, it’s an essential edge for the ones building, leading, and betting on this industry.
17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2026 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy